Russell Investments Group
HARP

Russell Investments Group’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

Russell Investments Group’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,264
Closed -$175K – 3268
2021
Q2 		$175K Hold
1,264
– – ﹤0.01% 2946
2021
Q1 		$264K Sell
1,264
-575
-31% -$115K ﹤0.01% 2757
2020
Q4 		$304K Sell
1,839
-1,758
-49% -$272K ﹤0.01% 2621
2020
Q3 		$608K Buy
3,597
+1,263
+54% +$182K ﹤0.01% 2308
2020
Q2 		$386K Buy
2,334
+156
+7% +$24.3K ﹤0.01% 2486
2020
Q1 		$251K Buy
2,178
+54
+3% +$7.59K ﹤0.01% 2466
2019
Q4 		$315K Buy
+2,124
New +$322K ﹤0.01% 2563

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Russell Investments Group's HARP Position: Q3 2021 in Review

Russell Investments Group sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2021, closing a stake of 1,264 shares — an estimated $175K sold.

Russell Investments Group first reported a position in HARP in Q4 2019 and held it in 7 quarters. The position peaked at $608K in Q3 2020. 93 funds tracked by Wall St. Rank hold HARP as of Q3 2021.

  • Russell Investments Group reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Russell Investments Group sold 1,264 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2021, an estimated $175K.
  • Russell Investments Group first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2019 and held it in 7 quarters.
  • Russell Investments Group's Harpoon Therapeutics, Inc. Common Stock position peaked at $608K in Q3 2020.
  • 93 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2021.

Based on Russell Investments Group's 13F filing for Q3 2021, filed 8 Nov 2021.